US$ 21.59
asa guidelines for glp 1 drugs Anesthetic Considerations Patients Taking Glucagon-Like Peptide-1 Agonists Glucagon‐like peptide‐1 receptor agonists: a
Description
Only peer-reviewed scientific journals were considered during the process

Scand J Gastroenterol

In a patient on GLP1 receptor agonist therapy presenting with a severalhour headache, mild dehydration, and serum sodium of 128 mmol/L, could the headache and hyponatremia be caused by the GLP1 medication?
That is real, and it should not be dismissed